Itron (NASDAQ:ITRI) Given “Buy” Rating at Roth Mkm

Itron (NASDAQ:ITRI)‘s stock had its “buy” rating reissued by investment analysts at Roth Mkm in a report released on Tuesday, Benzinga reports. They presently have a $102.00 price target on the scientific and technical instruments company’s stock. Roth Mkm’s price target suggests a potential upside of 8.78% from the company’s current price.

ITRI has been the subject of a number of other reports. Oppenheimer raised shares of Itron from a “market perform” rating to an “outperform” rating and set a $81.00 price target for the company in a research report on Friday, January 19th. TheStreet raised shares of Itron from a “c” rating to a “b-” rating in a research report on Monday, February 26th. Raymond James lowered shares of Itron from an “outperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Canaccord Genuity Group upgraded shares of Itron from a “hold” rating to a “buy” rating and lifted their price objective for the company from $68.00 to $105.00 in a research note on Tuesday, February 27th. Finally, Piper Sandler dropped their price objective on shares of Itron from $105.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, April 11th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $97.60.

Itron Stock Up 2.5 %

Shares of Itron stock traded up $2.31 during trading on Tuesday, hitting $93.77. 117,236 shares of the stock were exchanged, compared to its average volume of 401,589. The stock has a market cap of $4.30 billion, a price-to-earnings ratio of 45.08, a price-to-earnings-growth ratio of 0.99 and a beta of 1.41. The firm’s 50-day moving average price is $88.21 and its 200 day moving average price is $75.27. Itron has a 12-month low of $50.60 and a 12-month high of $96.73. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.43.

Itron (NASDAQ:ITRI) last announced its quarterly earnings results on Monday, February 26th. The scientific and technical instruments company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.75 by $0.48. Itron had a net margin of 4.46% and a return on equity of 12.27%. The firm had revenue of $577.17 million during the quarter, compared to analysts’ expectations of $569.90 million. During the same period in the previous year, the company earned $0.71 earnings per share. Itron’s quarterly revenue was up 23.5% compared to the same quarter last year. As a group, analysts forecast that Itron will post 3.61 earnings per share for the current fiscal year.

Insider Transactions at Itron

In other news, CFO Joan S. Hooper sold 1,560 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $75.37, for a total transaction of $117,577.20. Following the transaction, the chief financial officer now directly owns 60,141 shares in the company, valued at $4,532,827.17. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CEO Thomas Deitrich sold 1,912 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $75.37, for a total transaction of $144,107.44. Following the sale, the chief executive officer now owns 169,073 shares of the company’s stock, valued at $12,743,032.01. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Joan S. Hooper sold 1,560 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total transaction of $117,577.20. Following the sale, the chief financial officer now directly owns 60,141 shares in the company, valued at approximately $4,532,827.17. The disclosure for this sale can be found here. Insiders have sold a total of 30,467 shares of company stock worth $2,752,520 over the last ninety days. 1.45% of the stock is currently owned by company insiders.

Institutional Trading of Itron

Institutional investors have recently added to or reduced their stakes in the stock. Contravisory Investment Management Inc. boosted its holdings in Itron by 61.5% during the first quarter. Contravisory Investment Management Inc. now owns 344 shares of the scientific and technical instruments company’s stock worth $32,000 after buying an additional 131 shares in the last quarter. GAMMA Investing LLC purchased a new stake in Itron during the fourth quarter worth about $27,000. Covestor Ltd boosted its holdings in Itron by 9,150.0% during the third quarter. Covestor Ltd now owns 555 shares of the scientific and technical instruments company’s stock worth $34,000 after buying an additional 549 shares in the last quarter. Harvest Fund Management Co. Ltd purchased a new stake in Itron during the fourth quarter worth about $50,000. Finally, C M Bidwell & Associates Ltd. purchased a new stake in Itron during the fourth quarter worth about $76,000. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.